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Background: Both maternal pre-pregnancy obesity and excessive gestational weight gain are increasing in
prevalence and associated with a number of adverse pregnancy outcomes for both mother and child.
Observational studies regarding physical activity in pregnancy have found reduced weight gain in active mothers,
as well as reduced risk of adverse pregnancy outcomes. There is however a lack of high quality, randomized
controlled trials on the effects of regular exercise training in pregnancy, especially those with a pre-pregnancy
body mass index (BMI) at or above 30 kg/m
2.
Methods: We are conducting a randomised, controlled trial in Norway with two parallel arms; one intervention
group and one control group. We will enroll 150 previously sedentary, pregnant women with a pre-pregnancy BMI
at or above 30 kg/m
2. The intervention group will meet for organized exercise training three times per week,
starting in gestation week 14 (range 12-16). The control group will get standard antenatal care. The main outcome
measure will be weight gain from baseline to delivery. Among the secondary outcome measures are changes in
exercise capacity, endothelial function, physical activity level, body composition, serum markers of cardiovascular
risk, incontinence, lumbopelvic pain and cardiac function from baseline to gestation week 37 (range 36-38).
Offspring outcome measures include anthropometric variables at birth, Apgar score, as well as serum markers of
inflammation and metabolism in cord blood.
Discussion: The results of this trial will provide knowledge about effects of regular exercise training in previously
sedentary, obese pregnant women. If the program proves effective in reducing gestational weight gain and
adverse pregnancy outcomes, such programs should be considered as part of routine pregnancy care for obese
women.
Trial Registration: ClinicalTrials.gov: NCT01243554
Background
In the Unites States over one-third of reproductive age
women are obese (body mass index (BMI) ≥ 30 kg/m
2)
and another 29% are overweight (BMI 25.0-29.9 kg/m
2)
[1]. Maternal obesity is associated with a number of
adverse outcomes during and after pregnancy, such as
gestational diabetes, preeclampsia, caesarean delivery
and children born large for gestational age [2], as well
as increased risk for childhood obesity among offspring.
In addition, over 60% of overweight women gain more
than recommended during pregnancy [3]. As gestational
weight gain is directly associated with maternal weight
retained during the postpartum period [3] as well as
with offspring adiposity in childhood [4] and in early
adulthood [5], excess gestational weight gain could
accelerate the obesity epidemic. Current recommenda-
tions say that pregnant women should exercise with
moderate intensity for 30 minutes or more on most, if
not all, days of the week [6]. In general, women are not
active enough during pregnancy and women who have a
high pre-pregnancy BMI are even less likely to be physi-
cally active [7].
Today’s knowledge about the importance of exercising
regularly in controlling weight gain in pregnancy is
* Correspondence: trine.moholdt@ntnu.no
1Department of Public Health and General Practice, Norwegian University of
Science and Technology, Trondheim, Norway
Full list of author information is available at the end of the article
Moholdt et al. Trials 2011, 12:154
http://www.trialsjournal.com/content/12/1/154 TRIALS
© 2011 Moholdt et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.mainly based on results from observational studies
[4,8-11]. Previous randomized controlled trials of physi-
cal activity during pregnancy are few in number and
have had varying results. For example, Clapp et al [12]
found significantly less weight gain in women who were
randomized to high volume of exercise in late preg-
nancy, compared to moderate or low volumes, whereas
others have found no significant effects of exercise train-
ing on gestational weight gain [13-15]. The reasons for
the divergent results in these randomized trials could be
low compliance, high drop out rates and inadequate
number of participants in some of the studies, as well as
differences in the mode, frequency, intensity and dura-
tion of the exercise training. A reduced risk of excessive
weight gain has been found in women randomized to
lifestyle counselling programs combining diet and exer-
cise [16,17]. In such programs however, it is hard to say
if it is the exercise component or other factors that
make the women gain less weight in the intervention
groups. Thus, there is a lack of good quality randomized
controlled trials, assessing short and long term effects of
physical activity in pregnancy on mothers and offspring.
Especially, there is a need for studies looking at poten-
tial effects of regular exercise training during pregnancy
in obese mothers.
In this paper, we describe the methods of the Exercise
Training in Pregnancy (ETIP) trial, a randomized, con-
trolled trial of physical activity during pregnancy.
Methods
Objectives
The primary objective of the ETIP trial is to test the
hypothesis that obese pregnant women who exercise in
addition to usual pregnancy care will have a lower gesta-
tional weight gain compared to women who receive
usual care only.
Secondary, the ETIP trial will investigate the effects of
exercise training on various pregnancy-related complica-
tions, such as insulin resistance, lumbopelvic pain, urin-
ary and fecal incontinence, pelvic floor muscle
dysfunction, and prolonged labour. We will also assess
possible effects of exercise training on cardiopulmonary
parameters as cardiac function, submaximal oxygen
uptake, lactate threshold, heart rate recovery, endothelial
function, and blood pressure, measured as changes in
these parameters from early to late pregnancy. Offspring
variables include Apgar score, weight, length and head
circumference at delivery, prevalence of large for gesta-
tional age (LGA) and small for gestational age (SGA),
blood pressure, and body composition, and cord blood
markers of inflammation and insulin resistance.
Our hypothesis is that regular exercise training in
pregnancy will reduce gestational weight gain and preg-
nancy-related complications. We also hypothesise that
exercise will increase physical capacity, heart rate recov-
ery and endothelial function, and reduce blood pressure,
compared to the control group. Regarding offspring
variables, we hypothesise that exercise training will
reduce the prevalence of LG A ,b l o o dp r e s s u r e ,c o r d
blood markers of inflammation and insulin resistance, as
well as improve body composition, and Apgar score.
Participants and setting
We invite pregnant women with self-reported pre-preg-
nancy BMI ≥ 30 kg/m
2 to participate in the trial.
Women are eligible if they are 18 years or older, with a
singleton live fetus at an 11-14 weeks ultrasound scan.
Exclusion criteria are pregnancy complications, high risk
for preterm labour or diseases that could interfere with
participation, and habitual exercise training (twice or
more weekly). The women are given information about
the project and will be recruited through the ordinary
visits at general practitioners and midwives, and at out-
patient clinics at the hospitals. Also, information about
the study and invitation to participate is sent along with
the invitation to come for routine ultra sound scan in
week 18.
The trial will be conducted at the Norwegian Univer-
sity of Science and Technology and the St.Olavs Hospi-
tal, Trondheim University Hospital. The recruitment
started in September 2010 and will continue until the
needed number of participants is included, anticipated
until the end of 2012. Participating women get infant
food worth $85 US dollars.
Randomisation and allocation
After initial assessments, the women will be randomly
assigned to either intervention or control (1:1 randomi-
sation, Figure 1). Allocation is performed by a web-
based randomisation system developed and administered
by another unit at the university to ensure blinding. The
randomisation will be in blocks with varying block size.
Intervention
We invite the training group to participate in an exer-
cise program that we have specially designed for preg-
nancy, including aerobic activity, specific exercises for
stabilization of the lower back and pelvis, and strength
exercises for the pelvic floor muscles that we have spe-
cially designed for pregnancy. We conduct training
groups for a total of 60 minutes four times weekly at
the hospital. We ask the women to come to exercise
training a minimum of twice weekly between 14 and 37
weeks of gestation. We also encourage the women to
come for exercise training even after week 37. The
endurance training consists of a 10 minute warm-up fol-
lowed by walking on treadmills for 25 minutes. The
intensity will be moderate, reaching ~80% of their
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scale12-15) [18].
In addition, we instruct intervention women in a 50
minute home exercise program which we encourage
them to complete at least once per week (35 minutes
endurance training and 15 minutes strength exercises).
We also teach pelvic floor muscle exercises to do daily.
We also recommend the women to be physically active
in every-day life. Adherence is strongly emphasized and
registered in the women’s personal training diary and
the reports from the persons leading the training
groups. During the training period, the subjects will go
through motivational interviewing [19]. This is a client-
centred therapeutic method to enhance readiness for
change and to elicit the client’s own motivations for
change. Each woman will go through a 30 minute ses-
sion of motivational interviewing in each trimester.
They will also receive a weight gain curve that shows
the recommended weight gain throughout pregnancy,
based on 2009 Institute of Medicine guidelines [20]. The
training protocol follows recommendations from the
Norwegian Health Directory [21] and the American Col-
lege of Obstetrics and Gynecology [6]. Specific adjust-
ments are made to the exercise program if needed (for
e x a m p l eb yu s i n gas t a t i o n a r yb i k ei n s t e a do ft r e a d m i l l
walking and by modifying the strength exercises to the
actual strength level of the participants).
Women in the control group will receive the custom-
ary regular consultations with midwife, general practi-
tioner or obstetrician. They are not discouraged from
exercising on their own. Neither group will receive spe-
cial recommendations about diet, beyond what is given
through standard antenatal care. In Norway, the preg-
nancy care is free of charge. Routine prenatal visits are
done by general practitioners, midwives, or a combina-
tion of the two, and are usually undertaken in gesta-
tional weeks 8-12, 24, 28, 32, 36, 38, 40, and 41. In
addition, women are invited to an ultrasound scan is
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Figure 1 Flow-chart.
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about the actual advices about physical activity that pre-
natal care providers give to pregnant women, but the
guidelines from the Norwegian Health Directory [21]
are in line with the international guidelines [6].
Study assessment visits
We will see women for research visits at baseline (12-16
weeks of pregnancy), and again in week 37 (range 36-
38), as well at three months post partum (Figure 2). We
also obtain clinical measures that are collected during
the delivery hospitalization as well as through primary
care.
Primary outcome measure
The primary outcome measure is gestational weight
gain, calculated as the difference between weight mea-
sured at the time of inclusion and weight just before
d e l i v e r y .W em e a s u r em a t e r n a lb o d yw e i g h ta te n r o l -
ment and before delivery to the nearest 0.1 kg with a
calibrated electronic scale (SECA 770, Medema, Nor-
way) with participants wearing indoor clothing, without
shoes. Hospital staff will measure weight during the
delivery hospitalization using a different scale than at
baseline. We will calibrate the scales to ensure compar-
ability. If the hospital staff forget to weight the women,
we will use their self-reported weight at the time of
delivery as the outcome measure.
Secondary outcome measures
The maternal secondary outcome measurements are
outlined in Figure 2 and described more in detail below.
Blood sampling for fasting glucose concentrations and
the other blood markers will be taken after a 10 hour
overnight fast, and glucose tolerance will be measured
by a 2 hour 75 mg per-oral glucose tolerance test.
Gestational diabetes is diagnosed as fasting glucose ≥
6.9 mmol/L or 2 h concentration ≥ 7.8 mmol/L [22].
Insulin resistance will be calculated using the homeosta-
sis model assessment (HOMA-IR). We will analyse fast-
ing blood for concentrations of lipids, ferritin,
haemoglobin, high-sensitive C-reactive protein, and
insulin c-peptide. We will also collect whole blood and
serum to be frozen at -80C and stored in a biobank for
Activity monitor
for 5 days
Gestational week 14
Outcome variables 1
Cardiac function
Activity monitor
for 5 days
20 32 37 40
Outcome variables 1
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for 5 days
26 52
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Figure 2 Outcome variables and time-points of assessment.
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duction and blood markers associated with adiposity
and insulin resistance. We will also collect Tempus
blood RNA tubes and urinarysamples to be frozen for
later analyses.
Body height will be measured by a wall mounted
height scale. Body composition will be assessed by skin-
fold thickness during pregnancy and also by dual energy
x-ray absorptiometry (DEXA-scan) at three months
postpartum. Skinfold thickness will be measured at the
r i g h ts i d eo ft h eb o d ya tt h ef ollowing sites: triceps,
biceps, and subscapular, by Harpenden Caliper (Holtain
Ltd, UK). Sum of skinfold thickness are measured and
used for later calculation of body fat percentage. Waist
circumference is measured at all time points at the level
of the umbilicus. DEXA (Hologic Discovery-A: Integrity
Medical Systems) will be used to measure body compo-
sition after 10 hours of fasting, to decrease large varia-
tions in hydration status (postpartum only).
Lumbopelvic pain (Disability Rating Index) and physi-
cal examination of lumbar spine and pelvic region are
done by experienced physical therapists. Tests used are
active straight leg raising [23] and the posterior pelvic
pain provocation test [24].
Prevalence and severity of urinary- and fecal inconti-
nence will be assessed by questionnaires [25,26], muscle
strength measurements, 2D and 3D ultrasound investi-
gation of the pelvic muscles, and clinical examination
and palpation of the pelvic floor muscles. Pelvic floor
muscle strength, and vaginal squeeze pressure, will be
measured using a vaginal balloon catheter with a bal-
loon size of 6.7 × 1.7 cm connected to a pressure trans-
ducer [27].
Psychological well-being and postnatal depression will
be assessed using standardized questionnaires (The Psy-
chological General Well-Being inventory [28] and The
Edinburgh Postnatal Depression Scale [29], respectively).
Also, the women will fill in a questionnaire about deliv-
ery expectancy (The Wijma Delivery Expectancy/Experi-
ence Questionnaire [30]) Quality of life will be assessed
by the generic SF-8 Quality of life questionnaire [31].
To register diet during the intervention period, the
women will fill in a validated Norwegian quantitative
food frequency questionnaire [32].
Prevalence of pre-eclampsia will be registered by use
of the women’s health certificates. We will measure sys-
tolic and diastolic blood pressure with an automatic
device, after 15 minutes of supine resting and use the
average of three repeated measurements taken with two
minutes intervals. We will measure endothelial function
by flow-mediated dilatation of the brachial artery using
ultrasound (Vivid 7, GE Vingmed Ultrasound, Norway).
The women will fast and abstain from exercise, caffeine,
and smoking for ten hours, and rest for 10 minutes
before the measurements. The recordings are done 5
cm above the antecubital fossa before inflation of a
pneumatic cuff on the lower arm for 250 mm Hg for
five minutes, and again directly after cuff release and
for five minutes. The responses will be analysed by a
automatic detection program, and will be reported both
as absolute changes and as responses normalized by
dividing the percentage change in diameter by the shear
rate.
Physical activity will be registered by questionnaires.
Both groups will also wear a activity monitor (Sensewear
Armband, APC Cardiovascular, UK) to register their
level of daily physical activity for one week in early
(before week 17), mid (week 19-24) and late (after week
28) pregnancy. This armband includes a two-axis accel-
erometer, a heat flux sensor, a galvanic skin response
sensor, a skin temperatures e n s o ra n dan e a r - b o d y
ambient temperature sensor, and has been validated
during pregnancy (Berntsen et al, In review/in press
Acta Obstetrica et Gyencologia Scandinavia). In addi-
tion, the training group will fill in a training diary.
Maternal cardiac function will be measured using
echocardiography. The assessments will be done at week
14, week 20, and week 32, as well as 48 hours after
delivery, and again at three months post partum (Figure
2). A full resting echocardiogram will be performed with
a Vivid 7 scanner (GE Vingmed Ultrasound, Horten,
Norway) using a phased-array transducer. Three cine
loops from the three standard LV apical planes (four-
chamber, two-chamber and long-axis), right ventricle
and LV parasternal view will be recorded in B- mode
and tissue Doppler mode simultaneously. Conventional
Doppler flow parameters will be measured as well as tis-
sue Doppler imaging with pulsed tissue Doppler in the
AV-plane and strain/strain rate of the 16 segments of
the left ventricle (with tissue Doppler and speckle track-
ing). For automated identification of myocardial seg-
ments and analysis, we will use a customized post-
processing system (GcMat, GE-Vingmed, Horten,
Norway).
Multistage submaximal exercise tests will be done on
treadmills. After familiarizing with walking on a tread-
mill and 2-3 minutes of warming up, the test begins
with walking at 4,5 km/h and 0% inclination. Each stage
is 4 minutes and the inclination is elevated 3% each
stage. Heart rate and oxygen uptake will be measured
continuously during the test. Blood lactate, blood pres-
sure and perceived exertion (according to the Borg 6-20
scale, [18]) will be recorded at the end of each stage.
Tests are terminated if the subjects are feeling unwell
(have symptoms of pain, nausea, or dizziness), if the
heart rate exceeds 185 beats per minute, or if systolic
and diastolic blood pressure exceeds 200 and 100
mmHg, respectively.
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tial complications. Offspring variables include are out-
lined in Figure 2, and include the child’s condition at
birth and in the newborn period, birth weight, birth
length, head circumference, subscapular and triceps
skinfold thickness, upper-arm- and mid-abdominal cir-
cumferences, cord blood markers of inflammation and
insulin resistance, and blood pressure. The child’sc o n -
dition include Apgar scores at one and five minutes as
recorded by the attending mid-wife or physician, birth
traumas, need for extra oxygen, transfer to neonatal
intensive care unit, and diagnosis. The anthropometric
measurements will be standardized according to
Vik et al [33].
We intend to follow the children at age 3 and 12
months. At these time points we will also register breast
feeding and the use of supplementary feeding, as well as
crying behaviour according to Wessel et al [34]. Neuro-
motor development will be recorded through milestones,
a n db yu s i n gt h ea g ea n ds t a g e sq u e s t i o n n a i r ea t1 2
months of age [35]. This instrument has been validated
in Norway [36]. We also intend to follow these children
for a longer time in order to study possible long term
effects of in utero exposure to maternal exercise
training.
Sample size
Based on prior studies [37,38], the power calculation has
taken into account a 6 kg expected and clinically rele-
vant difference between mean weight increases in the
control group compared to the training group (between
baseline and delivery). Based on this assumption, an
independent samples t-test, 5% level of significance and
test strength of 0.90, gives a study population of 59 in
each group. A 15% estimated drop-out requires a total
of 150 included obese pregnant women, 75 enrolled in
each arm.
Ethical considerations
The Regional Committee for Medical Research Ethics
has approved the study, and it will be conducted in
accordance with the Declaration of Helsinki. All
mothers will give their informed, written consent to
participate.
Blinding
Baseline measurements, except for the armband regis-
tration of physical activity, will be done before rando-
misation. Later assessments will be done both blinded
(echocardiography, pelvic floor assessments, blood ana-
lyses, all offspring variables) and non-blinded to group
allocation (weight, skinfold measurements, lumbopelvic
pain, oxygen uptake and endothelial function record-
ings). Although endothelial function recordings are
done non-blinded, the analyses of these data will be
done blinded to both group allocation and time of
measurement.
Statistical methods
The principal analysis will be done on an intention-to-
treat basis; outcome measures will be analyzed accord-
ing to the treatment arm to which patients are rando-
mized regardless of subsequent crossover or non-
adherence. To model the outcome variables over time,
we will use a linear mixed effects model [39]. Age, par-
ity, and BMI will be considered as potential covariates
to improve precision. We will also do post-hoc compari-
sons of time points within groups, looking at within-
group changes in outcome variables from gestational
week 14 to 37, as well as from gestational week 37 to 12
weeks post partum.
In addition to the primary analysis, we will split the
women according to if they have actually been exercis-
ing during pregnancy or not. The cut-off for this analy-
sis will be: 1) attending ≥ 42 organised exercise sessions,
or 2) attending ≥ 28 exercise sessions + performing ≥ 28
home exercise sessions, or 3) performing ≥ 60 home
exercise sessions. To count as a home exercise session,
the exercise should be ≥ 50 minutes (either aerobic or
strength training) of at least moderate intensity. We also
intend to compare women fulfilling the general recom-
mendations for healthy adults of exercising moderately
for 30 minutes daily [40], with the ones below this
threshold. Results will be given as mean values with 95%
confidence intervals. P-values < 0.05 will be considered
significant.
Discussion
Maternal obesity is regarded a high-risk obstetric condi-
tion and is associated with pregnancy complications and
adverse outcomes [2]. In addition, there is increasing
evidence that gestational weight gain may be an impor-
tant predictor of the women’s risk of subsequent obesity
and diabetes. It has therefore been proposed that preg-
nancy is a unique period of time with regard to chan-
ging women’s behaviour [41]. In the present study, we
aim to prevent excess gestational weight gain and obe-
sity related pregnancy complications through regular
exercise training throughout pregnancy.
A recent study showed that approximately 60% of
overweight women gain more than recommended dur-
ing pregnancy, and as gestational weight gain associates
with weight retained during the postpartum period [3],
excess gestational weight gain could accelerate the obe-
sity epidemic. Thus the prevention of weight gain in
overweight and obese pregnant women is an important
public health issue. Further, maternal obesity is asso-
ciated with a number of adverse outcomes during and
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sia, caesarean delivery and children large for gestational
age [2]. The risk for gestational diabetes is increased 2-3
fold with obesity, and fetuses of obese mothers have
higher risk of developing insulin resistance in utero [42].
Greater maternal gestational weight gain has also
repeatedly been found to associate with offspring adip-
osity in childhood [4] and in early adulthood [5]. As
obese children have elevated levels of inflammatory mar-
kers related to cardiac disease manifested later in life
[43], they will be at increased risk for subsequent cardi-
ovascular disease. Importantly, there are indications in
the recent literature that the prenatal environment plays
a role for children obesity, independent of genetic pre-
disposition and shared eating habits [44,45].
Strengths of our study include the thorough testing
that will be done of the women as well as their off-
spring; investigating possible effects of exercise training
on weight gain, endothelial function, insulin resistance,
cardiac function, incontinence problems, lumbopelvic
pain, and psychological wellbeing. In addition we collect
comprehensive information on physical activity, using
both subjective and objective measurements (question-
naire and armband activity registrations, respectively), as
well as on dietary habits. Also regarded as a strength of
the study, is the composition of the exercise training
program, comprising both endurance training, general
strength training and specific pelvic floor exercises.
A possible weakness of our study is that it could be
underpowered for small differences in gestational weight
gain between groups. Also, we think that women who
like to participate in this kind of study are motivated for
exercise and thereby that some of the women in the
control group will do regular exercise training on their
own. Such cross-over from the control group would
potentially lead to smaller between-group differences.
The results from our study will give grounds for giv-
i n ga d v i c ea sw e l la so r g a n i z i n ge x e r c i s et r a i n i n gg r o u p s
for women with obesity entering pregnancy. If women
randomized to training manage to reduce their gesta-
tional weight gain compared to controls, such programs
should be considered as part of the regular pregnancy
care for this high-risk obstetric group.
In addition to effects on weight gain, we hope to see a
reduction in other pregnancy complications. Our study
will investigate the ability of regular exercise training to
prevent gestational diabetes mellitus, as well as the
effect on serum biomarkers associated with insulin resis-
tance and inflammation. Previous work have found that
exercise training may reduce lumbopelvic pain [46,47],
however, a preventive effect of exercise during preg-
nancy remains unclear. Pregnancy and childbirth may
also cause urinary and fecal incontinence, and obesity is
an additional risk factor. The average prevalence of
urinary incontinence during pregnancy and after deliv-
ery is 30-40%, and of fecal incontinence after delivery 4-
5% [48]. Specific pelvic floor muscle exercises in preg-
nancy and post partum reduce urinary incontinence,
while the preventive effect on fecal incontinence is less
documented [49].
Although observational evidence is quite consistent
regarding the association between large gestational
weight gain and offspring adiposity, the evidence for
causality is still lacking. It is possible that the intrauter-
ine experience of infants born to mothers who gain a
lot when pregnant programs long-term weight regula-
tion, or the maternal weight gain could just be a marker
of other, shared causes of both maternal and offspring
weight [50]. The optimal way to explore the impact of
the intrauterine exposure upon child adiposity, would be
to randomized women to usual care or to an effective
intervention limiting gestational weight gain, and then
to follow the infants longitudinally. To our knowledge,
no such adequately powered, randomized trial has been
done to investigate the possible causality between excess
gestational weight gain and child obesity. The rando-
mized trial we propose here will provide evidence for
such a causal relationship.
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